Pharmesis International Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pharmesis International Ltd with three other
pharmaceutical manufacturers in Asia:
Medicamen Biotech Limited
sales of 672.76 million Indian Rupees [US$10.47 million]
Rui Kang Pharmaceutical Group Investments Ltd
of Hong Kong
(86.57 million Hong Kong Dollars [US$11.09 million]
Godavari Drugs Ltd
based in India
(711.21 million Indian Rupees [US$11.07 million]
During the year ended December of 2016, sales at
Pharmesis International Ltd were 14.29 million Singapore Dollars (US$10.45 million).
increase of 4.5%
versus 2015, when the company's sales were 13.67 million Singapore Dollars.